17:11:21 EDT Thu 02 May 2024
Enter Symbol
or Name
USA
CA



Ndatalyze Corp
Symbol NDAT
Shares Issued 41,027,425
Close 2024-01-02 C$ 0.13
Market Cap C$ 5,333,565
Recent Sedar Documents

Ndatalyze outlines YMI business model

2024-01-03 11:31 ET - News Release

Dr. Keith Courtney reports

NDATALYZE CORP. ("NDAT" OR THE "CORPORATION") (CSE:NDAT) (OTC:NDATF) OPERATIONAL UPDATE AND BUSINESS MODEL EXPLANATION

Ndatalyze Corp. has provided an update on the corporation's business operations and explains its business model.

Introduction: In addressing the pressing challenges of the mental health crisis, Ndatalyze presents a revolutionary solution -- the YMI clinical decision support system, an advanced data analysis tool that represents a fundamental change to the way mental conditions are diagnosed and treated. This transformative tool aims to substantially improve both mental health diagnosis rates and treatment, thereby helping elevate overall societal mental health. The following outlines the strategic approach that underlies YMI's business model.

The problem: As published in the National Library of Medicine, between 2011 and 2030, the cumulative economic output loss associated with mental disorders is projected to be $16.3-trillion (U.S.) worldwide, making the economic output loss related to mental disorders comparable with that of cardiovascular diseases, and higher than that of cancer, chronic respiratory diseases and diabetes. Unfortunately, current mental condition diagnostic methods are wrong over half the time; essentially a coin toss that is often followed by inappropriate drug prescriptions with poor results and unwanted side effects. This prevalent trial-and-error approach hinders patient well-being, congests mental health systems and contributes to an overall decline in societal mental health.

YMI solution: YMI addresses the root causes of misdiagnosis by leveraging an objective, fact-based reference database and clinician-guided machine learning algorithms. This approach replaces subjective patient opinions with well-informed diagnostic predictions that are consistent, rapid and less biased; fundamentally altering the diagnostic and treatment landscape.

Strategic approach with a three-step strategy: YMI's evolution involves three crucial steps -- 1. creating the system, 2. establishing credibility through clinical studies and 3. penetrating the market through a series of relationships. The company has already completed step 1 -- YMI is fully functional and on-line today.

Step 2 -- clinical studies for credibility: Continuing studies to involve the Canadian Mental Health Association, and renowned professionals, Dr. Andrew Greenshaw, Dr. Bo Cao and Dr. Dale Stevens, aim to validate YMI's effectiveness and explore the benefits of DNA data integration.

Step 3 -- market penetration: To become the preferred mental condition diagnostic tool across Canada and the United States, YMI aims to forge relationships with governmental health authorities and health insurance companies, as is evident in recent news releases.

Revenue generation -- usage fees and licensing: Ndatalyze anticipates recurring revenue through usage fees for each YMI system use, and/or licensing agreements. Target markets include governmental health care systems, private health care insurers, risk-based businesses like insurance companies, airlines, police and security, and trucking/shipping industries.

Capital sufficiency: The corporation has ample capital to finance continuing studies.

Reporting: Preliminary results from clinical studies are expected within the next 120 days, with updates on the progress thereafter.

About YMI

YMI uses evidence-based, objective data from whole life experiences to predict individual mental states over time, and applies this knowledge toward a fuller understanding of how mental health develops, and how to improve mental well-being. YMI combines supervised machine learning with a proprietary reference database to predict an individual's predisposition toward a variety of common mental conditions, both current and forward in time.

Ndatalyze's YMI is poised to revolutionize mental health diagnoses while ensuring a sustainable revenue stream. By strategically addressing the causes of misdiagnosis, establishing credibility through clinical studies and targeting key markets, YMI aligns both societal impact and financial success.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.